Randomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer: Randomized Phase 2 Study of EZN-2208Christopher R Garrett,Tanios Bekaiisaab,Theresa Ryan,George A Fisher,S Clive,P Kavan,E Shachamshmueli,Aby Buchbinder,Richard M GoldbergCancer(2013)引用 62|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要